ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA

Clinical trials for ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA trials appear

Sign up with your email to follow new studies for ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for advanced liver cancer patients in groundbreaking trial

Disease control Recruiting now

This study is testing whether adding a new drug called RBS2418 to an existing immunotherapy combination works better for people with advanced liver cancer that cannot be removed by surgery. About 220 participants will receive either the standard immunotherapy alone or the standar…

Matched conditions: ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA

Phase: PHASE2 • Sponsor: Riboscience, LLC. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA

Get alerted when new ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA trials appear

New hope for advanced liver cancer patients in groundbreaking trial